We're back after a short summer hiatus with a deep dive into the world of biotech and health care:

The biotech sector has been under pressure this year, but innovations in AI and breakthroughs in dealing with chronic diseases are helping to renew investor interest. Yaron Werber, Managing Director, Senior Biotechnology Analyst, TD Cowen, joins host Kim Parlee, Vice President, TD Wealth, to talk sector challenges and exciting developments in obesity, cardiology, endocrinology and more.

Full English transcript here: https://www.moneytalkgo.com/video/biotech-in-focus-is-the-sector-poised-for-a-comeback/

Full French transcript here: https://www.moneytalkgo.com/fr/video/gros-plan-sur-la-biotechnologie-le-secteur-est-il-sur-le-point-de-rebondir/

*Recorded on Sept. 3, 2025